Search

Champions Oncology Inc

Cerrado

SectorSanidad

4.98 -1.97

Resumen

Variación precio

24h

Actual

Mínimo

4.98

Máximo

5.26

Métricas clave

By Trading Economics

Ingresos

241K

-426K

Ventas

1.4M

15M

P/B

Media del Sector

35.118

56.432

BPA

-0.03

Margen de beneficios

-2.797

Empleados

214

EBITDA

79K

-95K

Dividendos

By Acuity

Próximas Ganancias

14 dic 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-4M

68M

Apertura anterior

6.95

Cierre anterior

4.98

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

115 / 339 Clasificación en Healthcare

Champions Oncology Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

18 sept 2026, 20:02 UTC

Champions Oncology Inc shares fell slightly, continuing a downward trend since Thursday, despite an early recovery during Friday's trading session.

17 sept 2026, 20:01 UTC

News

Champions Oncology reported record annual revenue of $59.4 million for fiscal 2026, with shares trading higher amid a positive adjusted EBITDA of $1.6 million.

16 sept 2026, 19:06 UTC

Champions Oncology Inc is trading higher, experiencing significant volatility with a sharp midday rise after an initial dip, contrasting with three prior sessions that closed lower.

15 sept 2026, 20:03 UTC

News

Champions Oncology reports a net loss of $426,000 and revenue of $15.2 million. Shares are lower amid broader market declines following weak manufacturing data.

11 sept 2026, 19:56 UTC

News

Champions Oncology reported Q1 fiscal 2027 revenue of $15.2 million. Shares are lower despite improved gross margin and adjusted EBITDA of approximately $700,000.

10 sept 2026, 20:01 UTC

Champions Oncology Inc shares are higher today, continuing upward momentum after three consecutive sessions of decline. The stock remains above its 20-day moving average.

9 sept 2026, 20:07 UTC

Champions Oncology Inc shares declined for a fourth straight day, reaching a session low earlier. No specific news was identified to explain the movement.

8 sept 2026, 20:13 UTC

Champions Oncology Inc shares are lower in after-market hours, continuing a trend of declining performance over the past three sessions.

4 sept 2026, 19:07 UTC

Champions Oncology Inc is trading lower after reversing early gains, reflecting a decline since Thursday's close amid unchanged unemployment rates and decelerating wage growth.

3 sept 2026, 20:01 UTC

Champions Oncology Inc shares are higher today, maintaining strong upward momentum since Wednesday's close, despite no specific news to explain the movement.

2 sept 2026, 20:08 UTC

Champions Oncology Inc shares are higher today, breaking from a recent pattern of daily gains. No specific news was identified to explain the movement.

28 ago 2026, 19:36 UTC

Champions Oncology Inc. shares are trading roughly flat, with no specific news identified. The stock remains near the lower end of its one-month range.

27 ago 2026, 20:03 UTC

Champions Oncology shares are higher Thursday, reflecting a broader market trend amid declining initial jobless claims reported by the Labor Department.

25 ago 2026, 19:16 UTC

Champions Oncology Inc. is trading higher today, despite a flat performance and remaining below its 20-day moving average. No specific news was identified.

24 ago 2026, 20:06 UTC

News

Champions Oncology reports gross revenue of $59.42 million, with shares declining since Friday's close despite an earlier session increase.

21 ago 2026, 20:06 UTC

Champions Oncology Inc shares are lower in Friday's session amid broader market declines, with no specific news identified to explain the volatility.

20 ago 2026, 19:31 UTC

Champions Oncology Inc is higher today, driven by gains in the Life Sciences Tools & Services sub-sector, despite earlier session declines.

19 ago 2026, 20:02 UTC

Champions Oncology Inc shares declined during Wednesday's session, reaching a low in late morning amid no specific news to explain the downturn.

18 ago 2026, 19:41 UTC

Champions Oncology Inc shares are higher today, despite no specific news. Broader market concerns include inflation and rising treasury yields affecting investor sentiment.

17 ago 2026, 19:36 UTC

Champions Oncology Inc's shares are higher during Monday's session, reflecting a modest increase since Friday's close. The stock remains below its 20-day moving average.

14 ago 2026, 20:02 UTC

Champions Oncology is trading lower, reflecting broader market sentiment amid a surprising decline in U.S. retail sales for July.

13 ago 2026, 19:26 UTC

Champions Oncology Inc shares are higher during Thursday's session, rebounding from an earlier dip despite remaining below the 20-day moving average.

12 ago 2026, 19:51 UTC

Champions Oncology Inc's shares are lower today, diverging from recent gains, with no specific news identified to explain the decline.

11 ago 2026, 19:41 UTC

Champions Oncology Inc shares are lower today amid no specific news. The stock remains below its 20-day moving average and near the month's low.

10 ago 2026, 19:31 UTC

Champions Oncology Inc shares are lower, continuing a decline since Friday's close. The stock remains near its one-month range's lower end.

7 ago 2026, 19:42 UTC

Champions Oncology Inc shares are higher, driven by gains in the Life Sciences Tools & Services sub-sector. Earlier, they pulled back from a session high.

6 ago 2026, 19:32 UTC

Champions Oncology Inc shares are lower, continuing a downward trend amid broader market concerns over inflation and Federal Reserve policy. No specific news was identified.

5 ago 2026, 19:31 UTC

Champions Oncology Inc shares are lower during Wednesday's session, reflecting significant volatility amid broader market conditions and a notable drop in crude oil prices.

4 ago 2026, 19:51 UTC

Champions Oncology Inc shares are lower today, influenced by a decline in the Life Sciences Tools & Services sub-sector. The stock remains below its 20-day moving average.

3 ago 2026, 20:13 UTC

Champions Oncology Inc shares are trading higher in after-market hours. Broader market momentum is supported by strong tech performances and positive sentiment ahead of economic data.

Comparación entre iguales

Cambio de precio

Champions Oncology Inc previsión

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

Sentimiento

By Acuity

115 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.